IB-001 (IntegerBio)

N/A

Report date: 2026/02/25 20:02:36
NME

Base Information

Drug NameIB-001 (IntegerBio)
Drug Alias NameIB-001IB-001 (IntegerBio)
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIntegerBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntegerBio Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A